Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-ACETOXYCINNAMIC ACID, also known as O-Acetylsalicylic acid, is a chemical compound with the molecular formula C11H10O4. It is an ester of salicylic acid and acetic acid, known for its anti-inflammatory and analgesic properties. 2-ACETOXYCINNAMIC ACID is recognized for its potential therapeutic applications in medicine and as a synthetic building block in organic chemistry.

16189-10-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 16189-10-9 Structure
  • Basic information

    1. Product Name: 2-ACETOXYCINNAMIC ACID
    2. Synonyms: O-ACETYLCOUMARIC ACID;O-ACETOXYCINNAMIC ACID;2-ACETOXYCINNAMIC ACID;2-ACETYLCOUMARIC ACID;(E)-3-(2-Acetoxy-phenyl)-acrylic acid
    3. CAS NO:16189-10-9
    4. Molecular Formula: C11H10O4
    5. Molecular Weight: 206.19
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 16189-10-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 367.5°Cat760mmHg
    3. Flash Point: 145.4°C
    4. Appearance: /
    5. Density: 1.267g/cm3
    6. Vapor Pressure: 4.75E-06mmHg at 25°C
    7. Refractive Index: 1.592
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 2-ACETOXYCINNAMIC ACID(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-ACETOXYCINNAMIC ACID(16189-10-9)
    12. EPA Substance Registry System: 2-ACETOXYCINNAMIC ACID(16189-10-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 16189-10-9(Hazardous Substances Data)

16189-10-9 Usage

Uses

Used in Pharmaceutical Industry:
2-ACETOXYCINNAMIC ACID is used as a precursor in the synthesis of various pharmaceutical compounds for its versatile chemical properties and potential to be transformed into a range of therapeutic agents.
Used in Medical Treatments:
2-ACETOXYCINNAMIC ACID is used as an anti-inflammatory and analgesic agent for the treatment of conditions such as arthritis and cardiovascular disease, due to its ability to reduce inflammation and alleviate pain.
Used in Organic Chemistry:
2-ACETOXYCINNAMIC ACID is used as a building block in the synthesis of various organic compounds, contributing to the development of new chemical entities with potential applications in different fields.

Check Digit Verification of cas no

The CAS Registry Mumber 16189-10-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,1,8 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 16189-10:
(7*1)+(6*6)+(5*1)+(4*8)+(3*9)+(2*1)+(1*0)=109
109 % 10 = 9
So 16189-10-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H10O4/c1-8(12)15-10-5-3-2-4-9(10)6-7-11(13)14/h2-7H,1H3,(H,13,14)/b7-6-

16189-10-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-3-(2-acetoxyphenyl)acrylic acid

1.2 Other means of identification

Product number -
Other names azanyl diphenyl phosphate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16189-10-9 SDS

16189-10-9Relevant articles and documents

COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY

-

Page/Page column 108; 178-179, (2020/05/12)

The present invention provides new prodrags of Sunitinib, Brinzolamide, and Dorzolamide and compositions to treat medical disorders, for example glaucoma, a disorder or abnormality related to an increase in intraocular pressure (TOP), a disorder requiring neuroprotection, age-related macular degeneration, or diabetic retinopathy.

Synthesis of a series of benzothiazole amide derivatives and their biological evaluation as potent hemostatic agents

Nong, Wenqian,Zhao, Anran,Wei, Jinrui,Cheng, Hui,Luo, Xuan,Lin, Cuiwu

, p. 6231 - 6241 (2018/02/19)

A series of benzothiazole amide derivatives were synthesized through a facile and efficient method via a nucleophilic acyl substitution reaction between 2-aminobenzothiazole and various cinnamic acid compounds. The obtained products exhibited good thermal stabilities. All compounds were evaluated for their in vitro hemostatic activities using the commercially available standard drug etamsylate as a positive control. The results showed that compound Q2 had a significant partial coagulation activity, reduced capillary permeability at 5, 10 and 50 μmol L-1, activated thrombin activity, and a more potent platelet aggregation activity than the positive control group (etamsylate, up to 1283.9 times in the nanomole range). A molecular modeling study revealed that compound Q2 was a competitive thrombin activator. Therefore, Q2 may be a potential lead for further biological screening and for the generation of drug molecules. Moreover, the structure-activity relationship of the prepared compounds is also discussed herein.

Synthesis of novel 1,2,5-oxadiazoles and evaluation of action against Acinetobacter baumannii

Christoff, Rebecca M.,Murray, Gerald L.,Kostoulias, Xenia P.,Peleg, Anton Y.,Abbott, Belinda M.

supporting information, p. 6267 - 6272 (2017/10/13)

With multidrug resistant bacteria on the rise, novel antibiotics are becoming highly sought after. In 2008, eleven compounds were identified by high throughput screening as inhibitors of BasE, a key enzyme of the non-ribosomal peptide synthetase pathway found in Acinetobacter baumannii. Herein, we describe the preparation of four structurally similar heterocyclic lead compounds from that study, including one 1,2,5-oxadiazole. A further library of 30 analogues containing the oxadiazole moiety was then generated. All compounds were screened against Acinetobacter baumannii and their minimum inhibitory concentration data is reported, with (E)-3-(2-hydroxyphenyl)-N-(4-methyl-1,2,5-oxadiazol-3-yl)acrylamide 32 found to have an MIC of 0.5 mM. This work provides the foundation for further investigation of 1,2,5-oxadizoles as novel inhibitors of A. baumannii.

Synthesis and biological evaluation of a new series of cinnamic acid amide derivatives as potent haemostatic agents containing a 2-aminothiazole substructure

Nong, Wenqian,Zhao, Anran,Wei, Jinrui,Lin, Xiao,Wang, Lisheng,Lin, Cuiwu

supporting information, p. 4506 - 4511 (2017/09/12)

Ten new cinnamic acid derivatives containing a 2-aminothiazole substructure were designed and synthesized. This series of compounds exhibited good thermostabilities as demonstrated by thermogravimetric analysis. In coagulation assays (prothrombin time, activated partial thromboplastin time and thrombin time) in vitro, most compounds demonstrated excellent activities to promote blood coagulation. Among the studied series, compounds N1, N4, N5 and W5 exhibited a significant coagulation activity. Further studies indicated that compound N5 (IC50 = 1.87 μmol/L) displayed the most suitable efficacy of promoting platelet aggregation than the clinically used haemostatic drug etamsylate (IC50 = 46.22 μmol/L). Furthermore, the relationship between the functional groups of the compounds and the corresponding blood coagulant activity was explored in this study.

Novel enzymatic synthesis of 4-O-cinnamoyl quinic and shikimic acid derivatives

Armesto, Nuria,Ferrero, Miguel,Fernandez, Susana,Gotor, Vicente

, p. 5784 - 5787 (2007/10/03)

The first direct synthesis of 4-O-cinnamoyl derivatives of quinic and shikimic acids were accomplished by regioselective esterification with Candida antarctica lipase A. For hydrocinnamic esters, enzymatic transesterification with vinyl esters gave excell

Two new improved approaches to the synthesis of coumarin-based prodrugs

Zheng, Ailian,Wang, Wei,Zhang, Huijuan,Wang, Binghe

, p. 4237 - 4254 (2007/10/03)

Our laboratory has recently reported the development of a coumarin- based, esterase-sensitive prodrug system for the preparation of prodrugs of amines, peptides, and peptidomimetics. Biological evaluations including animal studies have demonstrated the cl

SIDE REACTIONS IN THE PHASE TRANSFER CATALYZED WITTIG-HORNER SYNTHESIS. A CONVENIENT METHOD OF PREPARATION OF HYDROXYCINNAMIC ACIDS.

Chenault, J.,Dupin, J. F. E.

, p. 1059 - 1066 (2007/10/02)

Reaction between triethylphosphonoacetate and acetylated hydroxy aromatic aldehydes gives hydroxycinnamic acids except for ortho acetylated componds where the Knoevenagel product is sometimes obtained.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16189-10-9